pharmaphorum

MAY 12, 2022

People who trust pharma are more interested in using the industry’s services – making building confidence in the sector key to realising the potential of patient centricity. However, according to Jennifer Turcotte, pharma advisor in the company’s healthcare and life sciences division, there was also some good news.

Pharma Companies 98

Pharma Companies Life Science Compliance Branding 98

pharmaphorum

JANUARY 31, 2022

Creating personalised, compliant content is becoming increasingly important for life science companies as HCPs demand more from their digital content. Pharma companies created 3.5 Guidance for creating and maintaining compliance. Veeva is the global leader in cloud software for the life sciences industry.

Marketing 52

Marketing Life Science Compliance Pharma Companies 52

XTalks

NOVEMBER 9, 2023

XTALKS WEBINAR: Impacts of the New IVD Regulation (IVDR) for Manufacturers and Users Live and On-Demand: Tuesday, January 9, 2024, at 10am EST (4pm CET/EU-Central) Register for this free webinar to learn about the specific compliance requirements, risk assessments and quality management changes mandated by the IVDR.

FDA Approval 64

FDA Approval HR Genotype Life Science 64

XTalks

JANUARY 11, 2021

Companies outsource to gain access to specialized expertise and technology, scale pharmacovigilance (PV) activities, and reduce costs. However, the efficiency and effectiveness of externalized safety activities are below expectations for many biotech and pharma companies.

Pharma Companies 90

Pharma Companies Compliance Clinical Outsourcing Regulation 90

VirTrial

JANUARY 10, 2020

The competition highlights companies that demonstrated innovative solutions, technologies, and services that have the potential to make the greatest impact for biotech and pharma companies. The company was selected for its industry leading Virtual Care Management (VCM) program.

Clinical Trials 97

Clinical Trials Clinical Trials Clinical Research Pharma Companies 97

Delveinsight

AUGUST 20, 2021

Invasive options mainly surgeries that involve the injection of therapeutic agents into the anal canal or surgical repair of anal canal are often associted with patient relctance and non-compliance. However, pharma companies have taken the lead to expand in the Fecal Incontinence therapy market.

Marketing 98

Marketing Pharma Companies Life Science Compliance 98

XTalks

MAY 6, 2022

They discussed current challenges and solutions that life science companies and clinical development organizations have with the management of clinical data. To produce ethical results in a timely manner, life science companies should ensure that they have a robust and reliable clinical data pipeline in place.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

pharmaphorum

MAY 18, 2021

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. He takes us through the challenges of a successful launch and explains what pre-commercial companies need to focus on to hit their goals. “Ad-hoc approaches are not an option anymore.

Production 52

Production Sales Life Science Marketing 52

pharmaphorum

OCTOBER 3, 2022

Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses. About the author.

Branding 114

Branding Doctors Doctor Compliance 114

pharmaphorum

MAY 27, 2022

The possibilities are endless, and in the context of trial participation and access to medicine technologies could assist: Reduced assessment times and hence increased patient compliance. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. What comes next?

Clinical Trials 79

Clinical Trials Clinical Trials Trials Packaging 79

pharmaphorum

FEBRUARY 11, 2022

It’s our representation of tracking the deidentified, which is important from a privacy and compliance point of view,” Sun says. “It During the pandemic, numerous digital health companies flourished due to the necessity for virtual solutions, including Komodo Health. About the author.

Life Science 102

Life Science Engineer Development Big Data 102

pharmaphorum

MARCH 18, 2021

A way to ensure compliance is to make sure the voice is not recorded but analysed and the full text is purged in real-time, leaving only the summarised call notes. Pharma companies and sales reps need to adapt to their customer behaviours to stay relevant”. This can overcome any privacy concerns. But it doesn’t stop there.

Sales 52

Sales Pharma Companies Engineer Life Science 52

Delveinsight

SEPTEMBER 8, 2021

Especially in the field of Pharmaceutical & Life Sciences, a company’s all-around product life-cycle stages, which consist of planning, designing, constructing, product testing, and commissioning processes are provided by a Pharma Consultant. Pharma Consultant. Market Assessment & Operational Sales.

Marketing 52

Marketing Production Sales Life Science 52

pharmaphorum

NOVEMBER 25, 2021

Lastly, make the most of technology to streamline and minimise compliance risks, so your team can engage and manage communication effectively. Rethinking pharma’s events’ strategy. During the short period in which these changes occurred there was a steep learning curve for pharma companies trying to run digital events productively.

Pharma Companies 98

Pharma Companies Production Sales Marketing 98

pharmaphorum

JUNE 10, 2022

To compete now, companies need to own a larger portion of the treatment journey and the overall patient care experience. Commercial leaders should leverage the internal capabilities and centres of excellence that pharma companies are increasingly building.

Marketing 132

Marketing Engineer Bioinformatics Regulation 132

Drug Discovery World

APRIL 3, 2023

As life science operates globally, the vision for the business was always to bring aptamers as an antibody alternative to researchers worldwide. Addressing this need in the market has allowed us penetration to work with 75% of the top twenty pharma companies. Optimer binders are engineered to overcome these problems.

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

pharmaphorum

APRIL 19, 2021

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. It’s been eventful 12-month period for the UK biotech guru Clive Dix, who has just seen his company C4X Discovery clinch a major inflammatory diseases deal with Sanofi.

Vaccination 96

Vaccination Vaccine Life Science Antibody 96

Drug Discovery World

JANUARY 5, 2023

Frits Stulp and Aida Demneri , partners at Deloitte (including Iperion – a Deloitte business), outline how life sciences companies can play their part in driving change. This has implications for compliance and patient safety, as well as for operational and commercial efficiency. . Vision for global standardisation .

Life Science 52

Life Science Production Medicine Compliance 52

Drug Discovery World

AUGUST 10, 2023

In this article, Amplexor asks some of the company’s closest industry partners and BE THE EXPERT event speakers for their views on the biggest developments in the Life Sciences Regulatory sphere over the last 12 months – and explore some of the most prominent themes and priorities seen throughout 2023.

Production 98

Production Life Science Development Manufacturing 98